Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$36,695,537
-$27,033,861 QoQ
Shares Held
377,332
-52.8% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Dec 31, 2025CallValue
$2,787,750
CallShares
35,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,565,450,068 across 341 Biotechnology names. RVMD ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in RVMD
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,695,537 | 377,332 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,787,750 | 35,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $63,729,398 | 800,118 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,782,700 | 81,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $20,002,030 | 428,309 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $50,801,140 | 1,380,841 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,528,642 | 156,353 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $874,800 | 20,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $2,947,750 | 65,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $1,459,256 | 37,600 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $4,189,900 | 130,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $246,914 | 7,661 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $608,016 | 21,200 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $2,042,016 | 71,200 | Put | Sole | 2024-02-14 | |
| 2023-09-30 | $3,293,920 | 119,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $6,859,546 | 247,816 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $802,500 | 30,000 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $2,247,000 | 84,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $10,006,907 | 374,090 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,979,084 | 553,051 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,801,327 | 117,604 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $2,270,046 | 95,300 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $1,189,116 | 60,300 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $987,972 | 50,100 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $10,067,553 | 510,525 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,978,584 | 255,443 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $606,449 | 23,773 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $935,040 | 37,149 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,143,572 | 186,971 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,327,366 | 41,820 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $839,374 | 18,295 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,380,724 | 186,429 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $278,668 | 8,827 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,416,431 | 110,289 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||